ENIAYO EGBERONGBE: Open Payments
NPI 1295263515 · CRANSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,998 in 232 payments from 16 companies in 2025. Trend: 2023 $2,169 · 2024 $2,365 · 2025 $4,998
Food & beverage: $4,899Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $829 |
| Otsuka America Pharmaceutical, Inc. | 44 | $766 |
| Teva Pharmaceuticals USA, Inc. | 21 | $572 |
| Vanda Pharmaceuticals Inc. | 21 | $543 |
| Alkermes, Inc. | 15 | $349 |
| Neurocrine BioSciences, Inc. | 17 | $345 |
| Janssen Pharmaceuticals, Inc | 7 | $286 |
| Axsome Therapeutics, Inc. | 12 | $284 |
| E.R. Squibb & Sons, L.L.C. | 20 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $238 |
Products named: VRAYLAR, REXULTI, FANAPT, INGREZZA, AUSTEDO XR, SPRAVATO, Auvelity, ARISTADA.
Industry payments across RI — which companies pay providers there.
